首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolu
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolu
admin
2013-11-29
127
问题
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolution is based on the idea that the sicker people are, the more freedom they should have to try drugs that are not yet fully tested. For fifty years government policy has been driven by another idea: the fear that insufficiently tested medicines could cause deaths and injuries. The urgent needs of people infected with HIV, the AIDS virus, and the possibility of meeting them with new drugs have created a compelling countervailing force to the continuing concern with safety. As a result, government rules and practices have begun to change. Each step is controversial. But the shift has already gone far beyond AIDS. New ways are emerging for very sick people to try some experimental drugs before they are marketed. People with the most serious forms of heart disease, cancer, emphysema, Alzheimer’ s or Parkinson’ s disease, multiple sclerosis, epilepsy, diabetes, or other grave illnesses can request such drugs through their doctors and are likelier to get them than they would have been four years ago. "We’ve been too rigid in not making lifesaving drugs available to people who otherwise face certain death," says Representative Henry Waxman, of California, who heads the subcommittee that considers changes in drug-approval policies. "It’s true of AIDS, but it’s also true of cancer and other life- threatening diseases."
For the first time, desperate patients have become a potent political force for making new medicines available quickly. People with AIDS and their advocates, younger and angrier than most heart-disease or cancer patients, are drawing on two decades of gay activists’ success in organizing to get what they want from politicians. At times they found themselves allied with Reagan Administration deregulators, scientists, industry representatives, FDA staff members, and sympathetic members of Congress. They organized their own clinical trials and searched out promising drugs here and abroad. The result is a familiar Washington story: a crisis—AIDS—helped crystallize an informal coalition for reform.
AIDS gave new power to old complaints. As early as the 1970s the drug industry and some independent authorities worried that the Food and Do, g Administration’ s testing requirements were so demanding that new drugs were being unreasonably delayed. Beginning in 1972, several studies indicated that the United States had lost its lead in marketing new medicines and that breakthrough drugs—those that show new promise in treating serious or life-threatening diseases— had come to be available much sooner in other countries. Two high-level commissions urged the early release of breakthrough drugs. So did the Carter Administration, but the legislation it pro- posed died in Congress. Complaints were compounded by growing concern that "if we didn’t streamline policies, red tape wot, Id be an obstacle to the development of the biotechnology revolution," as Frank E. Young, who was the head of the FDA from 1984 to 1989, put it in an interview with me.
Young was a key figure in the overhaul of the FDA’s policies. A pioneer in biotechnology and a former dean of the University of Rochester’s medical school, he came to Washington with an agenda and headed the agency for five and a half years—longer than anyone else has since the 1960s. Young took the FDA job to help introduce new medicines created by biotechnology-- whose promise he had seen in his own gene-cloning lab--and to get experimental medicines to desperately iii people more quickly. He had seen people die waiting for new medicines because "they were in the wrong place at the wrong time," he said. That is now changing.
From the second paragraph, we learn that ______.
选项
A、AIDS people tend to get angrier than all cancer patients
B、AIDS people have learned some experience from homosexual people in dealing with politicians
C、AIDS people have got some representatives in government organizations
D、AIDS people often work together with gay activists
答案
B
解析
转载请注明原文地址:https://www.kaotiyun.com/show/vHhO777K
0
考博英语
相关试题推荐
ThedomesticeconomyintheUnitedStatesexpandedinaremarkablyvigorousandsteadyfashion.Therevivalinconsumerconfiden
Thelawofprivateinternationaltribunalswithrespecttoconflictsofinterestofarbitratorsisquiteextensive,albeitbyno
Thelawofprivateinternationaltribunalswithrespecttoconflictsofinterestofarbitratorsisquiteextensive,albeitbyno
Islanguage,likefood,abasichumanneedwithoutwhichachildatacriticalperiodoflifecanbestarvedanddamaged?Judgin
Themarveloustelephoneandtelevisionnetworkthathasnowenmeshedthewholeworld,makingallmenneighbors,cannotbeextend
Justiceinsocietymustincludebothafairtrialtotheaccusedandtheselectionofanappropriatepunishmentforthoseproven
TheearlyretirementofexperiencedworkersisseriouslyharmingtheUSeconomy,accordingtoanewreportfromtheHudsonInsti
Variousinnovationshavebeenintroducedaswaystobreakoffoursystemwhichforcesstudentsthroughaseriesofidenticalcla
Youheartherefrainallthetime:theU.S.economylooksgoodstatistically,butitdoesn’tfedgood.Whydoesn’tever-greater
TheInternetisaglobalnetworkthatconnectsothercomputernetworks,togetherwithsoftwareandprotocolsforcontrollingthe
随机试题
小李是北京某政法学院教务处的工作人员,法律系提交了2012级四个法律专业教学班的期末成绩单,为更好地掌握各个教学班学习的整体情况,教务处领导要求她制作成绩分析表,供学院领导掌握宏观情况。请根据考生文件夹下的“Excel素材.xlsx”文档,帮助小李完成20
用添弧的方法找出下图中邮递员的最优投递路线(▲代表邮局).
在Word中,利用______可以很直观地改变段落的缩进方式,也可以调整页的左右边距。
膀胱造影的术前准备,不包括
动物分泌雄激素的主要器官是()
A.五脏六腑病证B.表里经脉病证C.五脏病证D.六腑病证E.急性病证原穴主要治疗
吕某,女,15岁,为某市中学生,是一起抢劫案的目击证人,下列有关公安机关在询问吕某过程中应当遵守的规则包括:
物流成本管理的中心环节是物流成本()。
唐开元年间,高丽人与百济人因琐事在京师地区发生殴斗,两人被政府羁押审制。依唐律,该案应适用的法律是()(2018年一综一第39题)
WhenLauraLangankifoundextratowelsinthelaundrysmellinglemonyfresh,shenever【C1】______thatmeanther13-year-oldson
最新回复
(
0
)